AM
Avertix Medical
Medical Devices · United States · Founded 2001About
The Guardian has the unique ability to deliver detection of ACS/MI events well before a symptomatic patient would arrive at the ED via tactile, alarm and visual alerts and has the additional ability to rapidly detect arrhythmia's. The ALERTS trial showed a nearly 8 hour difference in patient presentation time to the ER with the device turned on versus patients in the sham control. Additionally Guardian was able to detect a significant number of silent MI's as well as a variety of other cardiac abnormalities. See the technology at www.avertix.com for more information
Company details may include data from People Data Labs, licensed CC BY 4.0.